Clinical trial
Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring
NCT02351050 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring
- Lead sponsor
- University Hospital Ostrava
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- November 30, 2017
- Enrollment
- 144 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.